187 related articles for article (PubMed ID: 34145980)
1. The impact of expanding health insurance coverage for anti-cancer drugs on cancer survival in Korea.
Cho DY; Park J; Kim DS
Cancer Med; 2021 Jul; 10(13):4555-4563. PubMed ID: 34145980
[TBL] [Abstract][Full Text] [Related]
2. Liver cirrhosis and cancer: comparison of mortality.
Chung W; Jo C; Chung WJ; Kim DJ
Hepatol Int; 2018 May; 12(3):269-276. PubMed ID: 29497986
[TBL] [Abstract][Full Text] [Related]
3. Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia.
Rodriguez-Acevedo AJ; Chan RJ; Olsen CM; Pandeya N; Whiteman DC; Gordon LG
BMC Cancer; 2021 Sep; 21(1):1055. PubMed ID: 34563142
[TBL] [Abstract][Full Text] [Related]
4. National reimbursement listing determinants of new cancer drugs: a retrospective analysis of 58 cancer treatment appraisals in 2007-2016 in South Korea.
Kim ES; Kim JA; Lee EK
Expert Rev Pharmacoecon Outcomes Res; 2017 Aug; 17(4):401-409. PubMed ID: 28010146
[TBL] [Abstract][Full Text] [Related]
5. Public health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China.
Xie Y; Valdimarsdóttir UA; Wang C; Zhong X; Gou Q; Zheng H; Deng L; He P; Hu K; Fall K; Fang F; Tamimi RM; Luo T; Lu D
Int J Cancer; 2021 Jan; 148(1):28-37. PubMed ID: 32621751
[TBL] [Abstract][Full Text] [Related]
6. Impact of public health insurance coverage of novel anticancer medication on medical expenditure and patient affordability in a provincial medical centre of China: a propensity score-matching analysis with the quasi-experimental design.
Diao Y; Lin M; Xu K; Huang J; Wu X; Li M; Sun J; Li H
BMJ Open; 2022 Feb; 12(2):e054713. PubMed ID: 35173004
[TBL] [Abstract][Full Text] [Related]
7. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
8. The impact of benefits coverage expansion of social health insurance: Evidence from Korea.
Lee HM; Ko H
Health Policy; 2022 Sep; 126(9):925-932. PubMed ID: 35817628
[TBL] [Abstract][Full Text] [Related]
9. How government insurance coverage changed the utilization and affordability of expensive targeted anti-cancer medicines in China: an interrupted time-series study.
Diao Y; Qian J; Liu Y; Zhou Y; Wang Y; Ma H; Wang X; Luo R; Wagner A; Sun J; Liu Y
J Glob Health; 2019 Dec; 9(2):020702. PubMed ID: 31673344
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Affordable Care Act's young adult insurance expansion on prescription drug insurance coverage, utilization, and expenditures.
Look KA; Arora P
Res Social Adm Pharm; 2016; 12(5):682-98. PubMed ID: 26632980
[TBL] [Abstract][Full Text] [Related]
11. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
[TBL] [Abstract][Full Text] [Related]
12. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
Lillard LA; Rogowski J; Kington R
Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
[TBL] [Abstract][Full Text] [Related]
13. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
Hong S; Youk T; Lee SJ; Kim KM; Vajdic CM
PLoS One; 2020; 15(7):e0234927. PubMed ID: 32678818
[TBL] [Abstract][Full Text] [Related]
14. Medicaid Expansion and Mortality Among Patients With Breast, Lung, and Colorectal Cancer.
Lam MB; Phelan J; Orav EJ; Jha AK; Keating NL
JAMA Netw Open; 2020 Nov; 3(11):e2024366. PubMed ID: 33151317
[TBL] [Abstract][Full Text] [Related]
15. Impacts of health insurance benefit design on percutaneous coronary intervention use and inpatient costs among patients with acute myocardial infarction in Shanghai, China.
Yuan S; Liu Y; Li N; Zhang Y; Zhang Z; Tao J; Shi L; Quan H; Lu M; Ma J
Pharmacoeconomics; 2014 Mar; 32(3):265-75. PubMed ID: 23975740
[TBL] [Abstract][Full Text] [Related]
16. Health Insurance and Colorectal Cancer Survival in Khon Kaen, Thailand.
Phimha S; Promthet S; Suwanrungruang K; Chindaprasirt J; Bouphan P; Santong C; Vatanasapt P
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1797-1802. PubMed ID: 31244302
[TBL] [Abstract][Full Text] [Related]
17. Making cents out of caring for patients.
Wickman JM; Jackson RA; Marquess JG
J Am Pharm Assoc (Wash); 1999; 39(2):116, 118-9. PubMed ID: 10200069
[No Abstract] [Full Text] [Related]
18. Improving the performance of social health insurance system through increasing outpatient expenditure reimbursement ratio: a quasi-experimental evaluation study from rural China.
Miao Y; Gu J; Zhang L; He R; Sandeep S; Wu J
Int J Equity Health; 2018 Jun; 17(1):89. PubMed ID: 29940956
[TBL] [Abstract][Full Text] [Related]
19. Cancer survival in Kentucky and health insurance coverage.
McDavid K; Tucker TC; Sloggett A; Coleman MP
Arch Intern Med; 2003 Oct; 163(18):2135-44. PubMed ID: 14557210
[TBL] [Abstract][Full Text] [Related]
20. Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis.
Liao KH; Ko BS; Chen LK; Hsiao FY
Clin Transl Sci; 2020 Nov; 13(6):1288-1297. PubMed ID: 32583962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
